Suscriptores   Asóciese  
Textos Completos Autorizados
SEVERIDADE CLINICA DA ESFEROCITOSE HEREDITARIA – MARCADORES ANALITICOS

v-estudie-lo-mejor.gif
Expertos Invitados





SEVERIDADE CLINICA DA ESFEROCITOSE HEREDITARIA – MARCADORES ANALITICOS

(especial para SIIC © Derechos reservados)
Dos possíveis parâmetros analíticos complementares estudados (MCHC, RDW, Hb/MCHC, Hb/RDW, MCHC/RDW, EPO, sTfR e CH), apenas o RDW e as razões Hb/MCHC, Hb/RDW e MCHC/RDW mostraram ser excelentes marcadores de severidade, e, portanto, marcadores complementares para a classificação clínica da EH.
Autor:
Susana Rocha
Columnista Experta de SIIC

Institución:
Universidade do Porto

Artículos publicados por Susana Rocha
Coautor
Susana Rocha* 
Docente Universitária, Universidade do Porto, Porto, Portugal*
Aprobación
2 de Agosto, 2011 		Primera edición
16 de Agosto, 2011 		Segunda edición, ampliada y corregida
7 de Junio, 2021

SEVERIDADE CLINICA DA ESFEROCITOSE HEREDITARIA – MARCADORES ANALITICOS


Artículo completo
(castellano)
Extensión:  +/-2.86 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes
Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Diagnóstico por Laboratorio, Hematología
Relacionadas: Bioquímica, Educación Médica, Medicina Familiar, Pediatría



Comprar este artículo
Extensión: 2.86 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Susana Rocha, Serviço de Bioquímica Facultade de Farmácia Universidade do Porto, 4050-047, Rua Aníbal Cunha, 164, Porto, Portugal
Bibliografía del artículo
[1]Bolton-Maggs PH, Stevens RF, Dodd NJ, Lamont G, Tittensor P, King MJ. Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol 2004; 126:455-474. [2]Delaunay J. The molecular basis of hereditary red cell membrane disorders. Blood Rev 2007; 21:1-20. [3]Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet 2008; 372:1411-1426. [4]del Giudice EM, Perrotta S, Nobili B, Specchia C, d'Urzo G, Iolascon A. Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood 1999; 94:2259-2262. [5]Garg PK, Kumar A, Teckchandani N, Hadke NS. Hereditary spherocytosis coexisting with Gilbert's syndrome: a diagnostic dilemma. Singapore Med J 2008; 49:e308-309. [6]Rocha S, Costa E, Ferreira F, et al. Hereditary spherocytosis and the (TA)nTAA polymorphism of UGT1A1 gene promoter region--a comparison of the bilirubin plasmatic levels in the different clinical forms. Blood Cells Mol Dis 2010; 44:117-119. [7]Shiota M, Asada J, Nishida H, et al. Hereditary spherocytosis in 3 children coexisting with UDP-glucuronyl transferase 1A1 deficiency. J Pediatr Hematol Oncol 2009; 31:121-123. [8]Sugita K, Maruo Y, Kurosawa H, et al. Severe hyperbilirubinemia in a 10-year-old girl with a combined disorder of hereditary spherocytosis and Gilbert syndrome. Pediatr Int 2007; 49:540-542. [9]Fukagawa N, Friedman S, Gill FM, Schwartz E, Shaller C. Hereditary spherocytosis with normal osmotic fragility after incubation. Is the autohemolysis test really obsolete? Jama 1979; 242:63-64. [10]Godal HC, Gjonnes G, Ruyter R. Does preincubation of the red blood cells contribute to the capability of the osmotic fragility test to detect very mild forms of hereditary spherocytosis? Scand J Haematol 1982; 29:89-93. [11]Korones D, Pearson HA. Normal erythrocyte osmotic fragility in hereditary spherocytosis. J Pediatr 1989; 114:264-266. [12]Streichman S, Gescheidt Y. Cryohemolysis for the detection of hereditary spherocytosis: correlation studies with osmotic fragility and autohemolysis. Am J Hematol 1998; 58:206-212. [13]Rocha S, Costa E, Catarino C, et al. Erythropoietin levels in the different clinical forms of hereditary spherocytosis. Br J Haematol 2005; 131:534-542. [14]Rocha S, Costa E, Rocha-Pereira P, et al. Erythrocyte membrane protein destabilization versus clinical outcome in 160 Portuguese Hereditary Spherocytosis patients. Br J Haematol 2010; 149:785-794. [15]Rocha S, Rebelo I, Costa E, et al. Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis. Eur J Haematol 2005; 74:374-380. [16]Rocha S, Vitorino RM, Lemos-Amado FM, et al. Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis. Blood Cells Mol Dis 2008; 41:5-9. [17]Iglauer A, Reinhardt D, Schroter W, Pekrun A. Cryohemolysis test as a diagnostic tool for hereditary spherocytosis. Ann Hematol 1999; 78:555-557. [18]Romero RR, Poo JL, Robles JA, Uriostegui A, Vargas F, Majluf-Cruz A. Usefulness of cryohemolysis test in the diagnosis of hereditary spherocytosis. Arch Med Res 1997; 28:247-251. [19]Streichman S, Gesheidt Y, Tatarsky I. Hypertonic cryohemolysis: a diagnostic test for hereditary spherocytosis. Am J Hematol 1990; 35:104-109. [20]Michaels LA, Cohen AR, Zhao H, Raphael RI, Manno CS. Screening for hereditary spherocytosis by use of automated erythrocyte indexes. J Pediatr 1997; 130:957-960. [21]Rocha S, Costa E, Ferreira F, et al. Erythropoiesis versus inflammation in Hereditary Spherocytosis clinical outcome. Clin Biochem 2011. In Press. [22]Kendall RG. Erythropoietin. Clin Lab Haematol 2001; 23:71-80. [23]Cooper AC, Mikhail A, Lethbridge MW, Kemeny DM, Macdougall IC. Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol 2003; 14:1776-1784. [24]Jelkmann W. Erythropoietin after a century of research: younger than ever. Eur J Haematol 2007; 78:183-205. [25]Macdougall IC, Cooper AC. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant 2002; 17 Suppl 11:39-43. [26]Means RT, Jr., Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992; 80:1639-1647.
Título español
 Bibliografía
 Artículo completo
(exclusivo a suscriptores)
 Autoevaluación
  Tema principal en SIIC Data Bases
 Especialidades

  English title
  Abstract
 Key words
Full text
(exclusivo a suscriptores)

Autor 
Artículos
Correspondencia
Patrocinio y reconocimiento
Imprimir esta página
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Acerca de SIIC   Estructura de SIIC   Fuentes informativas  

Sociedad Iberoamericana de Información Científica

Copyright siicsalud© 1997-2024 ISSN siicsalud: 1667-9008
ua31517